BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 31272391)

  • 1. Fecal microbiota transplantation for ulcerative colitis: a prospective clinical study.
    Tian Y; Zhou Y; Huang S; Li J; Zhao K; Li X; Wen X; Li XA
    BMC Gastroenterol; 2019 Jul; 19(1):116. PubMed ID: 31272391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.
    Paramsothy S; Kamm MA; Kaakoush NO; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R; Xuan W; Lin E; Mitchell HM; Borody TJ
    Lancet; 2017 Mar; 389(10075):1218-1228. PubMed ID: 28214091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora.
    Wei Y; Gong J; Zhu W; Tian H; Ding C; Gu L; Li N; Li J
    BMC Microbiol; 2016 Nov; 16(1):255. PubMed ID: 27809778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study.
    Fang H; Fu L; Li X; Lu C; Su Y; Xiong K; Zhang L
    Microb Cell Fact; 2021 Jan; 20(1):18. PubMed ID: 33468164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis.
    Kump P; Wurm P; Gröchenig HP; Wenzl H; Petritsch W; Halwachs B; Wagner M; Stadlbauer V; Eherer A; Hoffmann KM; Deutschmann A; Reicht G; Reiter L; Slawitsch P; Gorkiewicz G; Högenauer C
    Aliment Pharmacol Ther; 2018 Jan; 47(1):67-77. PubMed ID: 29052237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis.
    Dang X; Xu M; Liu D; Zhou D; Yang W
    PLoS One; 2020; 15(3):e0228846. PubMed ID: 32182248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
    Jacob V; Crawford C; Cohen-Mekelburg S; Viladomiu M; Putzel GG; Schneider Y; Chabouni F; OʼNeil S; Bosworth B; Woo V; Ajami NJ; Petrosino JF; Gerardin Y; Kassam Z; Smith M; Iliev ID; Sonnenberg GF; Artis D; Scherl E; Longman RS
    Inflamm Bowel Dis; 2017 Jun; 23(6):903-911. PubMed ID: 28445246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impacts of Fecal Microbiota Transplantation from Same Sex on the Symptoms of Ulcerative Colitis Patients.
    Shang S; Zhu J; Liu X; Wang W; Dai T; Wang L; Li B
    Pol J Microbiol; 2023 Sep; 72(3):247-268. PubMed ID: 37725892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes.
    Li Q; Ding X; Liu K; Marcella C; Liu X; Zhang T; Liu Y; Li P; Xiang L; Cui B; Wang J; Bai J; Zhang F
    Clin Transl Gastroenterol; 2020 Aug; 11(8):e00224. PubMed ID: 32955197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.
    Nishida A; Imaeda H; Ohno M; Inatomi O; Bamba S; Sugimoto M; Andoh A
    J Gastroenterol; 2017 Apr; 52(4):476-482. PubMed ID: 27730312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
    Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
    Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.
    Costello SP; Hughes PA; Waters O; Bryant RV; Vincent AD; Blatchford P; Katsikeros R; Makanyanga J; Campaniello MA; Mavrangelos C; Rosewarne CP; Bickley C; Peters C; Schoeman MN; Conlon MA; Roberts-Thomson IC; Andrews JM
    JAMA; 2019 Jan; 321(2):156-164. PubMed ID: 30644982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis.
    Ding X; Li Q; Li P; Zhang T; Cui B; Ji G; Lu X; Zhang F
    Drug Saf; 2019 Jul; 42(7):869-880. PubMed ID: 30972640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and mechanism of fecal microbiota transplantation in mice with experimentally induced ulcerative colitis.
    Zhang L; Ma X; Liu P; Ge W; Hu L; Zuo Z; Xiao H; Liao W
    Exp Biol Med (Maywood); 2021 Jul; 246(13):1563-1575. PubMed ID: 33926254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiome Changes in Patients with Active Left-Sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy.
    Schierová D; Březina J; Mrázek J; Fliegerová KO; Kvasnová S; Bajer L; Drastich P
    Cells; 2020 Oct; 9(10):. PubMed ID: 33066233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.
    Rossen NG; Fuentes S; van der Spek MJ; Tijssen JG; Hartman JH; Duflou A; Löwenberg M; van den Brink GR; Mathus-Vliegen EM; de Vos WM; Zoetendal EG; D'Haens GR; Ponsioen CY
    Gastroenterology; 2015 Jul; 149(1):110-118.e4. PubMed ID: 25836986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis.
    Ishikawa D; Sasaki T; Osada T; Kuwahara-Arai K; Haga K; Shibuya T; Hiramatsu K; Watanabe S
    Inflamm Bowel Dis; 2017 Jan; 23(1):116-125. PubMed ID: 27893543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capsulized Fecal Microbiota Transplantation Induces Remission in Patients with Ulcerative Colitis by Gut Microbial Colonization and Metabolite Regulation.
    Chen Q; Fan Y; Zhang B; Yan C; Zhang Q; Ke Y; Chen Z; Wang L; Shi H; Hu Y; Huang Q; Su J; Xie C; Zhang X; Zhou L; Ren J; Xu H
    Microbiol Spectr; 2023 Jun; 11(3):e0415222. PubMed ID: 37093057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis.
    Scaldaferri F; Pecere S; Petito V; Zambrano D; Fiore L; Lopetuso LR; Schiavoni E; Bruno G; Gerardi V; Laterza L; Pizzoferrato M; Ianiro G; Stojanovic J; Poscia A; Papa A; Paroni Sterbini F; Sanguinetti M; Masucci L; Cammarota G; Gasbarrini A
    Transplant Proc; 2016 Mar; 48(2):402-7. PubMed ID: 27109966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Siderophore-harboring gut bacteria and fecal siderophore genes for predicting the responsiveness of fecal microbiota transplantation for active ulcerative colitis.
    Yan J; Zhou G; Ren R; Zhang X; Zhang N; Wang Z; Peng L; Yang Y
    J Transl Med; 2024 Jun; 22(1):589. PubMed ID: 38915068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.